Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
1 other identifier
observational
300
1 country
1
Brief Summary
Through the parameters of liver stiffness and spleen stiffness obtained by combi-elastography technique, summarize and analyze the warning index of esophagogastric variceal bleeding in patients with cirrhosis, so as to provide a new and valuable technique for clinical diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2020
CompletedFirst Posted
Study publicly available on registry
November 23, 2020
CompletedStudy Start
First participant enrolled
December 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedJanuary 19, 2021
January 1, 2021
2 years
November 10, 2020
January 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
F index
F index is linked to the degree of liver fibrosis,and it can be available by ultrasound elastography checking.
baseline
A index
A index is linked to the degree of hepatitis ,and it can be available by ultrasound elastography checking.
baseline
Spleen stiffness
Spleen stiffness can be available by ultrasound elastography checking.
baseline
Eligibility Criteria
Patients with liver cirrhosis and the gastroscopy is in line with the indications of portal hypertension.
You may qualify if:
- years old, no gender limit;
- The clinical diagnosis is in line with patients with liver cirrhosis caused by chronic hepatitis B, and the gastroscopy is in line with the indications of portal hypertension;
- Gastroscopy needs to provide the degree of gastroesophageal varices;
- Sign the informed consent form.
You may not qualify if:
- Patients with cirrhosis and portal hypertension because of other causes or combined with other causes(such as viral hepatitis other than hepatitis B,Autoimmune liver disease, alcoholic liver disease, metabolism-related fatty liver disease, etc.)
- Patients with a history of spleen-related operations, such as splenectomy, splenic embolism;
- Patients undergoing portosystemic shunt or TIPS;
- Isolated esophageal venous tumor and its bleeding patients;
- History of upper gastrointestinal tumor or bleeding from gastric ulcer , etc;
- Those with serious diseases of other systems that cannot cooperate with elastography examination, such as heart failure, renal failure, mental illness, etc;
- Ascites before liver and spleen result unable to complete elasticity examination;
- Pregnant patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chinese PLA General Hospital
Beijing, Beijing Municipality, 100853, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ping Liang, Doctor
Chinese PLA General Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief physician
Study Record Dates
First Submitted
November 10, 2020
First Posted
November 23, 2020
Study Start
December 31, 2020
Primary Completion
December 31, 2022
Study Completion
May 31, 2023
Last Updated
January 19, 2021
Record last verified: 2021-01